Literature DB >> 10869107

Expression of the PAX2 gene in human embryos and exclusion in the CHARGE syndrome.

A L Tellier1, J Amiel, A L Delezoide, S Audollent, J Augé, D Esnault, F Encha-Razavi, A Munnich, S Lyonnet, M Vekemans, T Attié-Bitach.   

Abstract

The CHARGE syndrome comprises ocular coloboma, heart malformation, choanal atresia, retarded growth and development, central nervous system malformations, genital hypoplasia, ear abnormalities, or deafness. The cause of the CHARGE syndrome remains unknown. In the present study, we analyzed the distribution pattern of the PAX2 gene in human embryos and found that PAX2 gene expression occurs in the primordia affected in the CHARGE syndrome. These data prompted us to consider the PAX2 gene a candidate gene in the CHARGE "association." We analyzed the PAX2 gene in 34 patients fulfilling the diagnostic criteria of the CHARGE syndrome for deletion and nucleotidic variations of the coding sequence and identified only polymorphisms. Our data suggest that mutation of the PAX2 gene is not a cause of the CHARGE association. However, the pattern of expression of PAX2 suggests that genes encoding downstream targets effectors could be candidate genes for the CHARGE syndrome. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10869107     DOI: 10.1002/1096-8628(20000717)93:2<85::aid-ajmg1>3.0.co;2-b

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  10 in total

1.  Comparative study of Pax2 expression in glial cells in the retina and optic nerve of birds and mammals.

Authors:  Jennifer Stanke; Holly E Moose; Heithem M El-Hodiri; Andy J Fischer
Journal:  J Comp Neurol       Date:  2010-06-15       Impact factor: 3.215

2.  Absent semicircular canals in CHARGE syndrome: radiologic spectrum of findings.

Authors:  A K Morimoto; R H Wiggins; P A Hudgins; G L Hedlund; B Hamilton; S K Mukherji; S A Telian; H R Harnsberger
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

3.  MRI of the olfactory bulbs and sulci in human fetuses.

Authors:  Robin Azoulay; Catherine Fallet-Bianco; Catherine Garel; Sophie Grabar; Gabriel Kalifa; Catherine Adamsbaum
Journal:  Pediatr Radiol       Date:  2005-12-08

Review 4.  Renal coloboma syndrome.

Authors:  Lisa A Schimmenti
Journal:  Eur J Hum Genet       Date:  2011-06-08       Impact factor: 4.246

5.  Copy number variations and primary open-angle glaucoma.

Authors:  Lea K Davis; Kacie J Meyer; Emily I Schindler; John S Beck; Danielle S Rudd; A Jason Grundstad; Todd E Scheetz; Terry A Braun; John H Fingert; Wallace L M Alward; Young H Kwon; James C Folk; Stephen R Russell; Thomas H Wassink; Val C Sheffield; Edwin M Stone
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-09       Impact factor: 4.799

6.  Typical renal-coloboma syndrome phenotype in a patient with a submicroscopic deletion of the PAX2 gene.

Authors:  Kucinskas Laimutis; Craig Jackson; Xinjie Xu; Berta Warman; Rudaitis Sarunas; Irena Andriuskeviciute; Pundziene Birute; Lisa A Schimmenti; Gordana Raca
Journal:  Am J Med Genet A       Date:  2012-05-11       Impact factor: 2.802

7.  Unique phenotype in a patient with CHARGE syndrome.

Authors:  Shobhit Jain; Hyung-Goo Kim; Felicitas Lacbawan; Irene Meliciani; Wolfgang Wenzel; Ingo Kurth; Josefina Sharma; Morris Schoeneman; Svetlana Ten; Lawrence C Layman; Elka Jacobson-Dickman
Journal:  Int J Pediatr Endocrinol       Date:  2011-10-13

8.  Ontogeny of the kidney and renal developmental markers in the rhesus monkey (Macaca mulatta).

Authors:  Cynthia A Batchelder; C Chang I Lee; Michele L Martinez; Alice F Tarantal
Journal:  Anat Rec (Hoboken)       Date:  2010-11       Impact factor: 2.227

9.  SNP genotyping to screen for a common deletion in CHARGE syndrome.

Authors:  Seema R Lalani; Arsalan M Safiullah; Susan D Fernbach; Michael Phillips; Carlos A Bacino; Laura M Molinari; Nancy L Glass; Jeffrey A Towbin; William J Craigen; John W Belmont
Journal:  BMC Med Genet       Date:  2005-02-14       Impact factor: 2.103

10.  Functional non-coding polymorphism in an EPHA2 promoter PAX2 binding site modifies expression and alters the MAPK and AKT pathways.

Authors:  Xiaoyin Ma; Zhiwei Ma; Xiaodong Jiao; J Fielding Hejtmancik
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.